Heart Tronics, Inc. (HRTT.PK), developer of the world’s only wireless, fully ambulatory, 12-lead ECG device fully compliant with the standards dictated by the American Heart Association, has announced that agencies affiliated with the United States of America finally agree that all ECG devices in current use are not efficacious at detecting the presence of coronary heart disease.
the United States Preventative Services Task Force’s July, 2012 findings
recommend against screening patients utilizing resting or exercise ECG
machines currently in use. The task
force also concluded that the use of current ECG machinery may actually be
harmful to patients by occasionally giving false positives results.
Tronics has cautioned the American public for the past decade about the risks
associated with utilizing ECG devices that are not compliant with guidelines
issued by the American Heart Association:
150 Hz high frequency digital filter cutoff for adult patients and 250
Hz high frequency cutoff for pediatric patients.
to James N. Fiedler, President and COO of Heart Tronics, Inc. and prior Senior
Executive for Sony Corporation of America and MCA, Inc. “the only ECG device
compliant with American Heart Association guidelines is the Heart Tronics, Inc.
device. The untold billions of dollars
wasted on machines that – simply – fail to do the job should be an outrage to
every American in this day and age.”
Fiedler further commented: “The
decade-long “cat and mouse” game with multiple United States governmental
agencies, including the Securities and Exchange Commission, has ended with egg
on their face, but that is no victory for anybody. Trillions of dollars have been wasted, and
millions of people have died when – all the while – the officials in Washington
knew the truth. The American Heart
Association guidelines have been available for decades and are not disputed by
anybody at any level of government or the public sector. These guidelines were simply ignored and, as
a direct result thereof, people died unnecessarily.”
that these responsible agencies of the United States of America have admitted
the truth, and in conjunction with our international work, we are compiling a
blue ribbon panel to determine the next steps in barring the use of substandard
machinery like that currently approved for use by Medicare.
U.S. Task Force Report is available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspsacad.htm
This press release and oral statements made regarding the subjects of this
release, contains forward-looking statements, within the meaning of the Private
Securities Litigation Reform Act of 1995, or the Reform Act, which may include,
but are not limited to, statements regarding or vaguely appertaining to revenue
estimates, plans, objectives, expectations and intentions and other statements
contained in this press release that are not historical facts, including
statements identified by words such as “believe,” “plan,” “seek,” “expect,”
“intend,” “estimate,” “anticipate,” “will,” and similar expressions. All
statements addressing operating performance, events, or developments that the
Corporation expects or anticipates will occur in the future, including statements
relating to sales growth, earnings or earnings per share growth, and market
share, as well as statements expressing optimism or pessimism about future
operating results or clinical outcomes, are forward-looking statements within
the meaning of the Reform Act. The forward-looking statements are based
on management’s current views and assumptions regarding future events and
operating performance, and are inherently subject to significant business,
economic, and competitive uncertainties and contingencies and changes in
circumstances, many of which are beyond Corporation control. The
statements in this press release are made as of the date of this press release,
even if subsequently made available by Corporation on its website or otherwise.
Corporation does not undertake any obligation to update or revise these
statements to reflect events or circumstances occurring after the date of this
Although the Company does not make forward-looking statements unless it
believes it has a reasonable basis for doing so, the Company cannot guarantee
their accuracy. The foregoing factors, among others, could cause actual
results to differ materially from those described in these forward-looking
statements. For a list of other factors which could affect the Company’s
results, including earnings estimates, see the Company’s very last Form 8-K on
filed with the Securities and Exchange Commission. No undue reliance
should be placed on any forward-looking statements.
Any inquiries contact James N. Fiedler at: firstname.lastname@example.org.